Anika Therapeutics | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data




Eps Cambiamento Data
Abbott USD 1.5 0.2 2025-12
Agenus USD -1.03 1.01 2025-03
Agios Pharmaceuticals USD -1.78 0.15 2025-09
Anika Therapeutics USD -0.34 1.16 2025-03
Arrowhead Research USD 0.22 0.33 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Halozyme Therapeutics USD 1.72 0.18 2025-09
Heron Therapeutics USD -0.03 0.03 2024-09
Insmed USD -1.75 0.05 2025-09
Integra LifeSciences USD 0.54 0.09 2025-09
Intrexon USD -0.1 0.03 2024-06
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 3.09 1.49 2025-09
MacroGenics USD 0.27 0.84 2025-09
Merit Medical Systems USD 0.92 0.09 2025-09
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.53 1.38 2025-12
Smith & Nephew USD 0.35 0.03 2025-12
Stryker USD 4.47 1.28 2025-12
Surmodics USD -0.25 0.28 2024-09
Veracyte USD 0.51 0.07 2025-09
Xencor USD -0.08 0.33 2025-09
Zimmer Biomet Holdings USD 2.42 0.52 2025-12


Anika Therapeutics Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.